Data / Form D filings / SalvaRx Group plc
SalvaRx Group plc: Form D filing
SalvaRx Group plc, a biotechnology company in Ramsey, Isle Of Man, filed a Form D with the SEC in 2016. The latest, on March 22, 2016, reports $340,450 sold of an offering with no set size to 2 investors.
Find out what SalvaRx Group plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- COMMERCE HOUSE, 1 BOWRING ROAD, Ramsey, Isle Of Man, IM8 2
- Phone
- 0)1624 811 611
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Isle Of Man
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1669673
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 22, 2016 | New notice | Indefinite | $340,450 | Indefinite | 2 | Mar 2, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kamlesh Shah | Executive Officer, Director | |
| Gregory Bailey | Director | |
| Ian Walters | Executive Officer, Director | |
| Richard Armstrong | Director | |
| James Mellon | Director | |
| Colin Weinberg | Director |
Every Form D from the week of Mar 21, 2016 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SalvaRx Group plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.